 | • レポートコード：20QY06-08365 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、変形性関節症用鎮痛剤のグローバル市場について種類別（経口、注射、外用）、用途別（医療、パーソナルケア）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・変形性関節症用鎮痛剤市場の概要 ・世界の主要地域別変形性関節症用鎮痛剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の変形性関節症用鎮痛剤市場規模2015-2026：種類別（経口、注射、外用） ・世界の変形性関節症用鎮痛剤市場規模2015-2026：用途別（医療、パーソナルケア） ・変形性関節症用鎮痛剤の北米市場規模2015-2020 ・変形性関節症用鎮痛剤のヨーロッパ市場規模2015-2020 ・変形性関節症用鎮痛剤の中国市場規模2015-2020 ・変形性関節症用鎮痛剤の日本市場規模2015-2020 ・変形性関節症用鎮痛剤の東南アジア市場規模2015-2020 ・変形性関節症用鎮痛剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Johnson & Johnson、Pfizer、GlaxoSmithKline、Mylan、Lilly、Sanofi、Abbott Laboratories、Bayer、Almatica Pharma、TEVA、Iroko Pharmaceuticals） ・変形性関節症用鎮痛剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・変形性関節症用鎮痛剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Osteoarthritis Pain Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Osteoarthritis Pain Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers:
Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Osteoarthritis Pain Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Osteoarthritis Pain Drugs industry.
Based on our recent survey, we have several different scenarios about the Osteoarthritis Pain Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8295.4 million in 2019. The market size of Osteoarthritis Pain Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Osteoarthritis Pain Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Osteoarthritis Pain Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Osteoarthritis Pain Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Osteoarthritis Pain Drugs market. The report also includes nautical information, where it shows Osteoarthritis Pain Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Osteoarthritis Pain Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Osteoarthritis Pain Drugs market.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
Geographical Analysis:
Based on region, the global Osteoarthritis Pain Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Osteoarthritis Pain Drugs market are
Johnson & Johnson
Pfizer
GlaxoSmithKline
Mylan
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Osteoarthritis Pain Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Osteoarthritis Pain Drugs market.
• The market share of the global Osteoarthritis Pain Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Osteoarthritis Pain Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Osteoarthritis Pain Drugs market.
1 Osteoarthritis Pain Drugs Market Overview
1.1 Osteoarthritis Pain Drugs Product Scope
1.2 Osteoarthritis Pain Drugs Segment by Type
1.2.1 Global Osteoarthritis Pain Drugs Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Pain Drugs Segment by Application
1.3.1 Global Osteoarthritis Pain Drugs Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Osteoarthritis Pain Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Osteoarthritis Pain Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Osteoarthritis Pain Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Osteoarthritis Pain Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Osteoarthritis Pain Drugs Industry
1.5.1.1 Osteoarthritis Pain Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Osteoarthritis Pain Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Osteoarthritis Pain Drugs Players to Combat Covid-19 Impact
2 Osteoarthritis Pain Drugs Estimate and Forecast by Region
2.1 Global Osteoarthritis Pain Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Osteoarthritis Pain Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
2.4.3 China Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
2.4.6 India Osteoarthritis Pain Drugs Estimates and Projections (2015-2026)
3 Global Osteoarthritis Pain Drugs Competition Landscape by Players
3.1 Global Top Osteoarthritis Pain Drugs Players by Sales (2015-2020)
3.2 Global Top Osteoarthritis Pain Drugs Players by Revenue (2015-2020)
3.3 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Pain Drugs as of 2019)
3.4 Global Osteoarthritis Pain Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Osteoarthritis Pain Drugs Players (Opinion Leaders)
4 Global Osteoarthritis Pain Drugs Market Size by Type
4.1 Global Osteoarthritis Pain Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Osteoarthritis Pain Drugs Price by Type (2014-2020)
4.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Type (2021-2026)
5 Global Osteoarthritis Pain Drugs Market Size by Application
5.1 Global Osteoarthritis Pain Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Osteoarthritis Pain Drugs Price by Application (2015-2020)
5.2 Global Osteoarthritis Pain Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Osteoarthritis Pain Drugs Price Forecast by Application (2021-2026)
3 North America Osteoarthritis Pain Drugs Market Facts & Figures
3.2 North America Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
3.3 North America Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
3.4 North America Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
4 Europe Osteoarthritis Pain Drugs Market Facts & Figures
4.2 Europe Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
5 China Osteoarthritis Pain Drugs Market Facts & Figures
5.2 China Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
5.3 China Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
5.4 China Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
6 Japan Osteoarthritis Pain Drugs Market Facts & Figures
6.2 Japan Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Osteoarthritis Pain Drugs Market Facts & Figures
7.2 Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
8 India Osteoarthritis Pain Drugs Market Facts & Figures
8.2 India Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
8.3 India Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
8.4 India Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Osteoarthritis Pain Drugs Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Osteoarthritis Pain Drugs Corporation Information
12.1.2 Johnson & Johnson Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson Osteoarthritis Pain Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer
12.2.1 Pfizer Osteoarthritis Pain Drugs Corporation Information
12.2.2 Pfizer Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.2.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Osteoarthritis Pain Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Osteoarthritis Pain Drugs Corporation Information
12.3.2 GlaxoSmithKline Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Osteoarthritis Pain Drugs Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Mylan
12.4.1 Mylan Osteoarthritis Pain Drugs Corporation Information
12.4.2 Mylan Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.4.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Osteoarthritis Pain Drugs Products Offered
12.4.5 Mylan Recent Development
12.5 Lilly
12.5.1 Lilly Osteoarthritis Pain Drugs Corporation Information
12.5.2 Lilly Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.5.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lilly Osteoarthritis Pain Drugs Products Offered
12.5.5 Lilly Recent Development
12.6 Sanofi
12.6.1 Sanofi Osteoarthritis Pain Drugs Corporation Information
12.6.2 Sanofi Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.6.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Osteoarthritis Pain Drugs Products Offered
12.6.5 Sanofi Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Osteoarthritis Pain Drugs Corporation Information
12.7.2 Abbott Laboratories Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Laboratories Osteoarthritis Pain Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Bayer
12.8.1 Bayer Osteoarthritis Pain Drugs Corporation Information
12.8.2 Bayer Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.8.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer Osteoarthritis Pain Drugs Products Offered
12.8.5 Bayer Recent Development
12.9 Almatica Pharma
12.9.1 Almatica Pharma Osteoarthritis Pain Drugs Corporation Information
12.9.2 Almatica Pharma Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Almatica Pharma Osteoarthritis Pain Drugs Products Offered
12.9.5 Almatica Pharma Recent Development
12.10 TEVA
12.10.1 TEVA Osteoarthritis Pain Drugs Corporation Information
12.10.2 TEVA Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.10.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 TEVA Osteoarthritis Pain Drugs Products Offered
12.10.5 TEVA Recent Development
12.11 Iroko Pharmaceuticals
12.11.1 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Corporation Information
12.11.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Business Overview and Total Revenue
12.11.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Products Offered
12.11.5 Iroko Pharmaceuticals Recent Development
13 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
13.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
13.4 Osteoarthritis Pain Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Osteoarthritis Pain Drugs Distributors List
14.3 Osteoarthritis Pain Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate by Type (2020-2026)
Table 2. Global Osteoarthritis Pain Drugs Sales (M Dose) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Osteoarthritis Pain Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Osteoarthritis Pain Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Osteoarthritis Pain Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Osteoarthritis Pain Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Osteoarthritis Pain Drugs Sales (M Dose) by Region (2015-2020)
Table 10. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Osteoarthritis Pain Drugs Revenue Share by Region (2015-2020)
Table 13. Global Osteoarthritis Pain Drugs Sales (M Dose) Forecast by Region (2021-2026)
Table 14. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Osteoarthritis Pain Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Osteoarthritis Pain Drugs (M Dose) of Key Companies (2015-2020)
Table 18. Global Osteoarthritis Pain Drugs Sales Share by Company (2015-2020)
Table 19. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Osteoarthritis Pain Drugs Revenue Share by Company (2015-2020)
Table 21. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Pain Drugs as of 2019)
Table 22. Global Osteoarthritis Pain Drugs Average Price (USD/K Dose) of Key Company (2015-2020)
Table 23. Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Osteoarthritis Pain Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Osteoarthritis Pain Drugs Players
Table 27. Global Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 28. Global Osteoarthritis Pain Drugs Sales Share by Type (2015-2020)
Table 29. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Osteoarthritis Pain Drugs Price (M Dose) by Type (2015-2020)
Table 31. Global Osteoarthritis Pain Drugs Sales Share by Type (2021-2026)
Table 32. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Osteoarthritis Pain Drugs Revenue Share by Type (2021-2026)
Table 34. Global Osteoarthritis Pain Drugs Price (M Dose) by Type (2021-2026)
Table 35. Global Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 36. Global Osteoarthritis Pain Drugs Sales Share by Application (2015-2020)
Table 37. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Osteoarthritis Pain Drugs Price (M Dose) by Application (2015-2020)
Table 39. Global Osteoarthritis Pain Drugs Sales (M Dose) by Application (2021-2026)
Table 40. Global Osteoarthritis Pain Drugs Sales Share by Application (2021-2026)
Table 41. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Osteoarthritis Pain Drugs Revenue Share by Application (2021-2026)
Table 43. Global Osteoarthritis Pain Drugs Price (M Dose) by Application (2021-2026)
Table 44. United States Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 45. United States Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 47. United States Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 49. United States Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 51. Europe Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 53. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 55. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 56. China Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 57. China Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 58. China Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 59. China Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 60. China Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 61. China Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 63. Japan Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 65. Japan Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 67. Japan Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 69. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 71. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 73. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
Table 74. India Osteoarthritis Pain Drugs Sales (M Dose) by Company (2015-2020)
Table 75. India Osteoarthritis Pain Drugs Sales Market Share by Company (2015-2020)
Table 76. India Osteoarthritis Pain Drugs Sales (M Dose) by Type (2015-2020)
Table 77. India Osteoarthritis Pain Drugs Sales Market Share by Type (2015-2020)
Table 78. India Osteoarthritis Pain Drugs Sales (M Dose) by Application (2015-2020)
Table 79. India Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 84. Johnson & Johnson Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 88. Pfizer Osteoarthritis Pain Drugs Product
Table 89. Pfizer Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 94. GlaxoSmithKline Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 98. Mylan Osteoarthritis Pain Drugs Product
Table 99. Mylan Recent Development
Table 100. Lilly Corporation Information
Table 101. Lilly Description and Business Overview
Table 102. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 103. Lilly Osteoarthritis Pain Drugs Product
Table 104. Lilly Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 108. Sanofi Osteoarthritis Pain Drugs Product
Table 109. Sanofi Recent Development
Table 110. Abbott Laboratories Corporation Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 113. Abbott Laboratories Osteoarthritis Pain Drugs Product
Table 114. Abbott Laboratories Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 117. Bayer Description and Business Overview
Table 118. Bayer Osteoarthritis Pain Drugs Product
Table 119. Bayer Recent Development
Table 120. Almatica Pharma Corporation Information
Table 121. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 122. Almatica Pharma Description and Business Overview
Table 123. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 124. Almatica Pharma Recent Development
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Business Overview
Table 127. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table 128. TEVA Osteoarthritis Pain Drugs Product
Table 129. TEVA Recent Development
Table . Iroko Pharmaceuticals Corporation Information
Table . Iroko Pharmaceuticals Description and Business Overview
Table . Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2015-2020)
Table . Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table . Iroko Pharmaceuticals Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Osteoarthritis Pain Drugs Distributors List
Table 138. Osteoarthritis Pain Drugs Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoarthritis Pain Drugs Product Picture
Figure 2. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Osteoarthritis Pain Drugs Market Share by Application in 2020 & 2026
Figure 6. Medical Care Examples
Figure 7. Personal Care Examples
Figure 8. Global Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate (2015-2026)
Figure 9. Global Osteoarthritis Pain Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Osteoarthritis Pain Drugs Price Trends Growth Rate (2015-2026) (USD/K Dose)
Figure 11. Global Osteoarthritis Pain Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Osteoarthritis Pain Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate (2015-2026)
Figure 15. Europe Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Osteoarthritis Pain Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Osteoarthritis Pain Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Osteoarthritis Pain Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Osteoarthritis Pain Drugs Players Market Share by Revenue in Osteoarthritis Pain Drugs 2015 & 2019
Figure 26. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Osteoarthritis Pain Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Osteoarthritis Pain Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Osteoarthritis Pain Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Osteoarthritis Pain Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 32. United States Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 33. Europe Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 34. Europe Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 35. Europe Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 36. China Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 37. China Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 38. China Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 39. Japan Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 40. Japan Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 41. Japan Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 45. India Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 46. India Osteoarthritis Pain Drugs Sales Market Share by Type in 2019
Figure 47. India Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 48. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Almatica Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Osteoarthritis Pain Drugs
Figure 61. Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure 62. Osteoarthritis Pain Drugs Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
変形性関節症疼痛ソリューション の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …- 変形性股関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hip Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hip Osteoarthri…
- 変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …
- 変形性関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medicine for Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medicine fo…
- 脊椎変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Ost…